Scilex Holding Co (SCLX)
Data as of , from SEC Form 4 filings.
See up to 3 months of SCLX. The 7-day demo opens the 1M and 3M ranges and puts SCLX on your watchlist.
Start 7-day demoData as of , from SEC Form 4 filings.
See up to 3 months of SCLX. The 7-day demo opens the 1M and 3M ranges and puts SCLX on your watchlist.
Start 7-day demo
Henry Ji - OfficerHenry Ji - OfficerHenry Ji - OfficerScilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
No Form 4 activity for SCLX in the last 90 days.
22 Form 4 filings on record, the earliest from Oct 17, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | Other | Common stock | 500,000 | - footnote F1 | - | |
| ||||||
| Stephen Hoi Ma - Officer | Open-market purchase | Warrant (right to buy) | 650,000 | $0.15 | $100K | |
| Henry Ji - Officer | Open-market purchase | Warrant (right to buy) | 3,250,000 | $0.15 | $500K | |
| Henry Ji - Officer | Open-market sale | Warrant (right to buy) | 650,000 | $0.15 | $100K | |
| Scilex Holding Co | Open-market sale | Common Stock | 3,689,016 | $0.75 | $2.77M | |
| Scilex Holding Co | Open-market sale | Common Stock | 7,310,984 | $0.66 | $4.79M | |
| Scilex Holding Co | Open-market sale | Common Stock | 9,657,300 | $0.54 | $5.21M | |
| Stephen Hoi Ma - Officer | Grant or award | Incentive Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Jay Chun | Grant or award | Nonstatutory Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Dorman Followwill | Grant or award | Nonstatutory Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Yue Alexander Wu | Grant or award | Nonstatutory Stock Option (right to buy) | 20,000 | $0.00 | - | |
| Henry Ji - Officer | Grant or award | Incentive Stock Option (right to buy) | 120,000 | $0.00 | - | |
| Jaisim Shah - Officer | Open-market purchase | Common Stock | 30,000 | $0.46 | $14K | |
| Jay Chun | Grant or award | Nonstatutory Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Dorman Followwill | Grant or award | Nonstatutory Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Yue Alexander Wu | Grant or award | Nonstatutory Stock Option (right to buy) | 100,000 | $0.00 | - | |
| Henry Ji - Officer | Open-market purchase | Common Stock | 8,888 | $0.94 | $8K | |
| Jaisim Shah - Officer | Open-market purchase | Common Stock | 32,000 | $0.99 | $32K | |
| Yue Alexander Wu | Open-market purchase | Common Stock | 20,000 | $0.95 | $19K | |
| Jay Chun | Open-market purchase | Common Stock | 5,000 | $0.95 | $5K | |
| David Lemus | Open-market purchase | Common Stock | 2,000 | $0.90 | $2K | |
| Dorman Followwill | Open-market purchase | Common Stock | 1,000 | $0.99 | $990 | |
| Henry Ji - Officer | Open-market purchase | Common Stock | 10,000 | $0.97 | $10K | |
| Jaisim Shah - Officer | Open-market purchase | Common Stock | 30,000 | $0.99 | $30K | |
| Stephen Hoi Ma - Officer | Open-market purchase | Common Stock | 6,700 | $0.97 | $6K | |
Scilex Holding Co (SCLX) has filed no insider reports in the last 90 days. The most recent on record is dated 8 July 2026. The full record for SCLX runs to 22 Form 4 filings, the earliest from 17 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
No insider purchases of SCLX were filed in the last 90 days. 12 purchases are on record for this company.
No insider sales of SCLX were filed in the last 90 days. 4 sales are on record for this company.
This page collects SCLX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
